Real‐world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO2S …

O Moreno‐Pérez, R Reyes‐Garcia… - Diabetes, Obesity …, 2024 - Wiley Online Library
1 BACKGROUND Type 2 diabetes guidelines recommend glucagon-like peptide-1 receptor
agonists (GLP-1 RAs) and/or sodium-glucose co-transporter-2 inhibitors for people living …
被引用次数：11 相关文章

Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO2 S …

O Moreno-Pérez, R Reyes-Garcia… - Diabetes, obesity & …, 2024 - pubmed.ncbi.nlm.nih.gov
Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A
nationwide multicentre retrospective observational study (ENDO2 S-RWD) Real-world …

[引用][C] Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO …

O Moreno-Pérez, R Reyes-Garcia… - Diabetes, Obesity & …, 2023 - europepmc.org
Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A
nationwide multicentre retrospective observational study (ENDO2 S-RWD). - Abstract - Europe …